Keli Walbert

Keli Walbert

Director/Board Member at SPRUCE BIOSCIENCES, INC.

Net worth: - $ as of 29/06/2026

59 year
Health Technology
Consumer Services

Profile

Keli Walbert is currently an Independent Director at Spruce Biosciences, Inc. since 2025.
Former positions include Independent Director at Apellis Pharmaceuticals, Inc. from 2025 to 2026, and Executive Vice President-US Commercial at Horizon Therapeutics Ltd. (Ireland) from 2019 to 2023.
Education includes graduate studies at Northwestern University and undergraduate studies at the University of Louisville.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/05/2026 0 ( -.--% ) - $ 29/06/2026

Keli Walbert active positions

CompaniesPositionStart
SPRUCE BIOSCIENCES, INC. Director/Board Member 10/12/2025

Former positions of Keli Walbert

CompaniesPositionEnd
APELLIS PHARMACEUTICALS, INC. Director/Board Member 13/05/2026
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 31/12/2022
See the detail of Keli Walbert's experience

Training of Keli Walbert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

21

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology